GDF11 and neoplasm: The second key finding of this study is the lower GDF11 H-score in the patients with tumor sizes ≥ 2 cm, pathologic stages T3 + T4, and AJCC stages III–IV (Table 2), which aligns with the findings of a previous study [40].